Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis

A Fernandez, P Asbell, N Roy - The Ocular Surface, 2022 - Elsevier
Ocular allergy remains a significant burden to the population while the treatment for the
severe, chronic forms of allergic conjunctivitis remains largely limited to non-specific …

Ultrasound-responsive peptide nanogels to balance conflicting requirements for deep tumor penetration and prolonged blood circulation

M Sun, T Yue, C Wang, Z Fan, E Gazit, J Du - ACS nano, 2022 - ACS Publications
A series of biological barriers need to be overcome for therapeutic nanocarriers
accumulating at the tumor site and uptaken by cancer cells. One strategy is to construct …

Ocular surface immune cell diversity in dry eye disease

AP Nair, S D'Souza, P Khamar… - Indian Journal of …, 2023 - journals.lww.com
Dry eye disease (DED) is a multifactorial chronic ocular surface inflammatory condition.
Disease severity has been directly related to the immuno-inflammatory status of the ocular …

Comparison of sodium-glucose cotransporter 2 inhibitors vs glucagonlike peptide-1 receptor agonists and incidence of dry eye disease in patients with type 2 diabetes …

YC Su, JH Hung, KC Chang, CC Sun… - JAMA network …, 2022 - jamanetwork.com
Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been found to improve
low-grade systemic and tissue inflammation; however, the association between SGLT2 …

Alleviating experimental allergic eye disease by inhibiting pro-lymphangiogenic VEGFR3 signal

B Lou, W Wu, L Zeng, W Zhou, X Zhang, X Zhou, Z Liu… - The Ocular Surface, 2022 - Elsevier
Purpose Ocular allergy leads to acute and chronic inflammation that may deteriorate the
conjunctiva and other ocular tissue. The conjunctiva is covered with abundant lymphatic …

Spontaneous acinar and ductal regrowth after meibomian gland atrophy induced by deletion of FGFR2 in a mouse model

X Yang, X Zhong, AJW Huang, LW Reneker - The ocular surface, 2022 - Elsevier
Purpose We have demonstrated that deletion of fibroblast growth factor receptor 2 gene
(Fgfr2) leads to Meibomian gland (MG) atrophy in an inducible conditional knockout mouse …

The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction

CJ Beatty, RE Ruiz-Lozano, ME Quiroga-Garza… - The Ocular Surface, 2024 - Elsevier
Meibomian gland dysfunction (MGD) is a leading cause of dry eye disease and one of the
most common ophthalmic conditions encountered in eye clinics worldwide. These holocrine …

Comparison of subjective responses to cyclosporine 0.05% versus lifitegrast 5.0% in individuals with dry eye disease

EVT Locatelli, KA Acuna, J Betz, AA Tovar, A Galor - Cornea, 2022 - journals.lww.com
Purpose: The aim of the study was to examine subjective responses to cyclosporine A (CsA)
0.05% versus lifitegrast 5% in individuals with dry eye disease. Methods: This study was a …

Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus

VG Lalgudi, R Shetty, KK Nischal, S Ziai… - Saudi Journal of …, 2022 - journals.lww.com
Keratoconus (KC) is a complex multifactorial corneal ectatic disorder, with disease onset
commonly in the second-third decades significantly affecting quantity, quality of vision, and …

Meibomian gland dysfunction: a route of ocular graft-versus-host disease progression that drives a vicious cycle of ocular surface inflammatory damage

VL Perez, HM Mousa, M Soifer, C Beatty… - American journal of …, 2023 - Elsevier
Purpose To investigate the role of aggressive meibomian gland dysfunction (MGD) in the
immune pathogenesis of ocular graft-vs-host disease (GVHD). Methods In mice, an …